Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2648

1.

Antioxidant status and reproductive hormones in women during reproductive, perimenopausal and postmenopausal phase of life.

Ogunro PS, Bolarinde AA, Owa OO, Salawu AA, Oshodi AA.

Afr J Med Med Sci. 2014 Mar;43(1):49-57.

PMID:
25335378
[PubMed - indexed for MEDLINE]
2.

Risks and effectiveness of compounded bioidentical hormone therapy: a case series.

Davis R, Batur P, Thacker HL.

J Womens Health (Larchmt). 2014 Aug;23(8):642-8. doi: 10.1089/jwh.2014.4770. Review.

PMID:
25111856
[PubMed - indexed for MEDLINE]
3.

Hormone therapy and venous thromboembolism among postmenopausal women.

Scarabin PY.

Front Horm Res. 2014;43:21-32. doi: 10.1159/000360554. Epub 2014 Jun 10. Review.

PMID:
24943295
[PubMed - indexed for MEDLINE]
4.

Hormone therapy and hemostasis among postmenopausal women: a review.

Canonico M.

Menopause. 2014 Jul;21(7):753-62. doi: 10.1097/GME.0000000000000296. Review.

PMID:
24937030
[PubMed - indexed for MEDLINE]
5.

All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.

Labrie F.

J Steroid Biochem Mol Biol. 2015 Jan;145:133-8. doi: 10.1016/j.jsbmb.2014.06.001. Epub 2014 Jun 9. Review.

PMID:
24923731
[PubMed - indexed for MEDLINE]
6.

Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women.

Stein P, Baldinger P, Kaufmann U, Christina RM, Hahn A, Höflich A, Kranz GS, Savli M, Wadsak W, Mitterhauser M, Winkler D, Kasper S, Lanzenberger R.

Psychoneuroendocrinology. 2014 Aug;46:52-63. doi: 10.1016/j.psyneuen.2014.04.008. Epub 2014 Apr 21.

PMID:
24882158
[PubMed - indexed for MEDLINE]
7.
8.

Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.

Kranz GS, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, Winkler D, Lanzenberger R, Kasper S.

Psychoneuroendocrinology. 2014 Jul;45:1-10. doi: 10.1016/j.psyneuen.2014.03.004. Epub 2014 Mar 20.

PMID:
24845171
[PubMed - indexed for MEDLINE]
9.

Is breast cancer risk the same for all progestogens?

Stute P.

Arch Gynecol Obstet. 2014 Aug;290(2):207-9. doi: 10.1007/s00404-014-3270-0.

PMID:
24838289
[PubMed - indexed for MEDLINE]
10.

Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.

Venkatesh KK, Cu-Uvin S.

Am J Reprod Immunol. 2014 Jun;71(6):495-504. doi: 10.1111/aji.12247. Review.

PMID:
24832617
[PubMed - indexed for MEDLINE]
11.

Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.

Rasgon NL, Kenna HA, Wroolie TE, Williams KE, DeMuth BN, Silverman DH.

Psychiatry Res. 2014 Jul 30;223(1):28-36. doi: 10.1016/j.pscychresns.2014.04.004. Epub 2014 Apr 15.

PMID:
24819305
[PubMed - indexed for MEDLINE]
12.

Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.

Smith GI, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1306-10. doi: 10.1210/jc.2013-4470. Epub 2014 Apr 2.

PMID:
24694337
[PubMed - indexed for MEDLINE]
13.

Risks and benefits of hormone therapy: has medical dogma now been overturned?

Shapiro S, de Villiers TJ, Pines A, Sturdee DW, Baber RJ, Panay N, Stevenson JC, Mueck AO, Burger HG.

Climacteric. 2014 Jun;17(3):215-22. doi: 10.3109/13697137.2014.905529. Epub 2014 Apr 23.

PMID:
24654673
[PubMed - indexed for MEDLINE]
14.

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.

Hosoda M, Yamamoto M, Nakano K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H.

Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19.

PMID:
24549642
[PubMed - indexed for MEDLINE]
15.

Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study.

Botelho MA, Queiroz DB, Barros G, Guerreiro S, Fechine P, Umbelino S, Lyra A, Borges B, Freitas A, Queiroz DC, Ruela R, Almeida JG, Quintans L Jr.

Clinics (Sao Paulo). 2014 Feb;69(2):75-82. doi: 10.6061/clinics/2014(02)01.

PMID:
24519196
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Factors associated with successful discontinuation of hormone therapy.

Newton KM, Reed SD, Nekhyludov L, Grothaus LC, Ludman EJ, Ehrlich K, LaCroix AZ.

J Womens Health (Larchmt). 2014 May;23(5):382-8. doi: 10.1089/jwh.2012.4200. Epub 2014 Jan 20.

PMID:
24443881
[PubMed - indexed for MEDLINE]
17.

Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.

Santen RJ, Kagan R, Altomare CJ, Komm B, Mirkin S, Taylor HS.

J Clin Endocrinol Metab. 2014 Mar;99(3):733-47. doi: 10.1210/jc.2013-3680. Epub 2014 Jan 1. Review.

PMID:
24423357
[PubMed - indexed for MEDLINE]
18.

[Menopause:old concept, real problem].

Yu Q.

Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):721-2. Chinese. No abstract available.

PMID:
24406125
[PubMed - indexed for MEDLINE]
19.

What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead?

Simon JA.

Menopause. 2014 Jul;21(7):769-83. doi: 10.1097/GME.0000000000000169.

PMID:
24398406
[PubMed - indexed for MEDLINE]
20.

Monthly haemostatic factor variability in women and men.

Hill AM, Stewart PW, Fung MK, Kris-Etherton PM, Ginsberg HN, Tracy RP, Pearson TA, Lefevre M, Reed RG, Elmer PJ, Holleran S, Ershow AG; Dietary Effects on Lipoproteins and Thrombogenic Activity Investigators.

Eur J Clin Invest. 2014;44(3):309-18. doi: 10.1111/eci.12235.

PMID:
24382103
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk